Skip to main content

Table 1 Participants characteristics at 48 weeks on ART

From: Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study

Variable

Category

Frequency (%)

Outcome of participants

Completed

180 (70.3%)

Lost to follow up

76 (29.6%)

Gender

Female

108 (60%)

Male

72 (40%)

Age (years)

Median

39

≤ 25 years

8 (4%)

26 – 31 years

20 (11%)

32–37 years

52 (29%)

38–43 years

48 (27%)

44–49 years

28 (16%)

≥ 50 years

24 (13%)

ART regimen

EFV

100 (55.5%)

NVP

80 (44.4%)

  1. Abbreviations: ART Antiretroviral therapy, EFV Efavirenz, NVP Nevirapine